tiprankstipranks
Trending News
More News >
Viking Therapeutics (DE:1VT)
FRANKFURT:1VT
Germany Market

Viking Therapeutics (1VT) Income Statement

Compare
75 Followers

Viking Therapeutics Income Statement

Last quarter (Q4 2025), Viking Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Viking Therapeutics's net income was $-157.66M. See Viking Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -431.00K$ 0.00$ -292.00K$ 0.00$ 0.00
Operating Expenses
$ 393.34M$ 150.92M$ 100.83M$ 70.36M$ 55.68M
Depreciation and Amortization
$ 431.00K$ 346.00K$ 292.00K$ 291.00K$ 296.00K
EBITDA
$ -393.34M$ -150.57M$ -100.53M$ -70.06M$ -55.39M
Operating Income
$ -393.34M$ -150.92M$ -100.83M$ -70.36M$ -55.68M
Other Income/Expenses
$ 33.70M$ 40.96M$ 14.93M$ 1.49M$ 692.00K
Pretax Income
$ -359.64M$ -109.96M$ -85.89M$ -68.87M$ -54.99M
Net Income
$ -359.64M$ -109.96M$ -85.89M$ -68.87M$ -54.99M
Per Share Metrics
Basic EPS
$ -3.19$ -1.01$ -0.91$ -0.88$ -0.70
Diluted EPS
$ -3.19$ -1.01$ -0.91$ -0.88$ -0.70
Weighted Average Shares Outstanding
112.67M 109.04M 94.35M 76.83M 77.20M
Weighted Average Shares Outstanding (Diluted)
112.67M 109.04M 94.35M 76.83M 77.20M
Currency in USD

Viking Therapeutics Earnings and Revenue History